[{"address1": "1400 Sierra Point Parkway", "address2": "Building C Suite 200", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "650 822 5500", "fax": "650 636 9773", "website": "https://www.annexonbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company's lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barr\u00e9 syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.", "fullTimeEmployees": 106, "companyOfficers": [{"maxAge": 1, "name": "Mr. Douglas E. Love Esq., J.D.", "age": 56, "title": "CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 1010807, "exercisedValue": 0, "unexercisedValue": 446927}, {"maxAge": 1, "name": "Dr. Ted  Yednock Ph.D.", "age": 66, "title": "Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 714668, "exercisedValue": 0, "unexercisedValue": 175585}, {"maxAge": 1, "name": "Dr. Jamie  Dananberg M.D.", "age": 66, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 715233, "exercisedValue": 0, "unexercisedValue": 154858}, {"maxAge": 1, "name": "Ms. Jennifer  Lew CPA", "age": 51, "title": "Executive VP, CFO & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 624195, "exercisedValue": 0, "unexercisedValue": 13124}, {"maxAge": 1, "name": "Dr. Dean R. Artis Ph.D.", "age": 63, "title": "Chief Scientific Officer & Executive VP", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 797380, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Overdorf M.B.A.", "age": 53, "title": "Executive VP & Chief Business Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 580469, "exercisedValue": 0, "unexercisedValue": 13124}, {"maxAge": 1, "name": "Mr. Henk-Andre  Kroon M.D.", "title": "Senior Vice President of Translational Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shikhar  Agarwal M.B.A.", "title": "Senior VP & Head of Commercial", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sunil  Mehta Pharm.D.", "title": "Senior VP of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 7, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.71, "open": 2.64, "dayLow": 2.4604, "dayHigh": 2.6799, "regularMarketPreviousClose": 2.71, "regularMarketOpen": 2.64, "regularMarketDayLow": 2.4604, "regularMarketDayHigh": 2.6799, "payoutRatio": 0.0, "beta": 1.259, "forwardPE": -2.1842105, "volume": 1041276, "regularMarketVolume": 1020021, "averageVolume": 1815712, "averageVolume10days": 1456480, "averageDailyVolume10Day": 1456480, "bid": 1.9, "ask": 3.18, "bidSize": 2, "askSize": 2, "marketCap": 273187872, "fiftyTwoWeekLow": 1.285, "fiftyTwoWeekHigh": 7.85, "fiftyDayAverage": 1.9306, "twoHundredDayAverage": 4.224725, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 61938036, "profitMargins": 0.0, "floatShares": 82380157, "sharesOutstanding": 109714000, "sharesShort": 9969617, "sharesShortPriorMonth": 9273824, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.090900004, "heldPercentInsiders": 0.00565, "heldPercentInstitutions": 1.0298, "shortRatio": 7.27, "shortPercentOfFloat": 0.11350001, "impliedSharesOutstanding": 109714000, "bookValue": 2.222, "priceToBook": 1.1206121, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -167380000, "trailingEps": -1.17, "forwardEps": -1.14, "enterpriseToEbitda": -0.343, "52WeekChange": -0.5354477, "SandP52WeekChange": 0.09203708, "quoteType": "EQUITY", "currentPrice": 2.49, "targetHighPrice": 14.0, "targetLowPrice": 9.0, "targetMeanPrice": 11.16667, "targetMedianPrice": 10.5, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 263696000, "totalCashPerShare": 2.403, "ebitda": -180756992, "totalDebt": 28308000, "quickRatio": 7.86, "currentRatio": 7.994, "debtToEquity": 11.612, "returnOnAssets": -0.3766, "returnOnEquity": -0.66133004, "freeCashflow": -71027248, "operatingCashflow": -139794000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANNX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1749859003, "regularMarketTime": 1749844801, "exchange": "NMS", "messageBoardId": "finmb_279883519", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -8.11808, "regularMarketPrice": 2.49, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1595597400000, "postMarketChangePercent": 7.83132, "postMarketPrice": 2.685, "postMarketChange": 0.195, "regularMarketChange": -0.22, "regularMarketDayRange": "2.4604 - 2.6799", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1815712, "fiftyTwoWeekLowChange": 1.205, "fiftyTwoWeekLowChangePercent": 0.93774325, "fiftyTwoWeekRange": "1.285 - 7.85", "fiftyTwoWeekHighChange": -5.3599997, "fiftyTwoWeekHighChangePercent": -0.6828025, "fiftyTwoWeekChangePercent": -53.544773, "marketState": "CLOSED", "earningsTimestamp": 1747051202, "earningsTimestampStart": 1754915400, "earningsTimestampEnd": 1755261000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.17, "epsForward": -1.14, "epsCurrentYear": -1.48851, "priceEpsCurrentYear": -1.6728138, "fiftyDayAverageChange": 0.55939996, "fiftyDayAverageChangePercent": 0.28975445, "twoHundredDayAverageChange": -1.7347248, "twoHundredDayAverageChangePercent": -0.4106125, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "shortName": "Annexon, Inc.", "longName": "Annexon, Inc.", "displayName": "Annexon", "trailingPegRatio": null, "__fetch_time": "2025-06-14"}]